To design the vaccines of the future we need to fully exploit microbial genomes and understand the basic mechanisms of the immune system. Existing vaccines have been developed mostly against ...

People fully vaccinated against hepatitis B who are not immunocompromised can expect sustained immunity throughout their ...

B, a new hepatitis vaccine, vs. standard hepatitis B vaccines as a booster in previously vaccinated individuals.

Even with significant expansion in the global market for antibodies used in clinical care and research, scientists recognize that there is still untapped potential for finding new antibodies.

Health care workers are at higher risk of hepatitis B infection due to occupational exposure to blood and body fluids.

With an ever increasing number of patients being treated with IVIg for a wide array of immune-mediated disease, it is important that passive antibody transfer is considered when unexpected ...

Harrison's plasma contained the rare antibody Anti-D, also known as Rhesus D antibody, which is used to make the medication given to mothers whose blood is at risk of attacking their fetuses.

They instruct B-cells to create antibodies that block the virus from ... but companies are using insect cells and yeast. The hepatitis B vaccine relies on a viral protein created by genetically ...